@usstocksnews | YouTube | VK Видео | Чат
🔹 Adj. EPS: $2.46 (Est. $2.44) 🟢; UP +21% YoY
🔹 Sales: $24.56B (Est. $24.15B) 🟢; UP +9% YoY
🔹 Innovative Medicine: $15.76B (Est. $15.4B) 🟢; +10% YoY
🔹 MedTech: $8.80B; UP +8% YoY
FY26 Guidance
🔹 Sales: $100B to $101B (Est. $98.9B) 🟢
🔹 Adj. EPS: $11.43 to $11.63 (Est. $11.49) 🟢
🔹 Adj. Operating EPS: $11.28 to $11.48
🔹 Operating Margin outlook: 31.5%
🔹 Expects operating income growth to be stronger in 2H’26 than 1H’26
Переходи в чат t.me/USstocksnews_chat
Компания объявила о намерении выделить свой ортопедический бизнес в отдельную компанию.
#jnj
